CALLUNA PHARMA AS
Operating
Å investere i farmasøytiske selskaper og virksomheter, herunder å
realisere slike investeringer, samt all annen virksomhet knyttet til
dette.
Utvikle, markedsføre og selge legemidler.
Organization
- CEO
- Chairman of the board
- MF
- Years since formation
- 3 years
- since Oct 14, 2023
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 10
Ownership
- Number of shares and share classes
- 74,167,000
- 3 share classes
- Total number of shareholders
- 6
- 3 companies, 3 persons
- Belongs to group of
Financials
- Total operating income 2025
- 36,344,416
- NOK
- Annual total result 2025
- -10,145,066
- NOK
Last update: Jul 30, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
MF | Chairman | - |
| Board Member | - | |
SS 1981 | Board Member | - |
FA | Board Member | - |
MB 1974 | Board Member | - |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - | |
| Auditor | - |
Last update: Feb 11, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 33,867,000 | 45.66 % | |
| Ordinary shares | 27,422,185 | 36.97 % | |
| Ordinary shares | 8,300,000 | 11.19 % | |
| Extraordinary shares | 3,463,451 | 4.67 % | |
| Extraordinary shares | 687,056 | 0.93 % | |
| J-shares | 427,308 | 0.58 % |
Shares owned by the CALLUNA PHARMA AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 26,043,511 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 36,344,416Operating profit 2025: NOK -16,003,910Employees: 10
Financials
in NOK
Summary
| Year | 2025 | 2023 |
|---|---|---|
Total operating income | 36,344,416 | 26,904,988 |
Annual Total Result | -10,145,066 | -11,910,670 |
Total assets | 0 | 853,584,265 |
Total liabilities | 0 | 84,317,125 |
Total equity | 0 | 769,267,140 |
P&L
| Year | 2025 | 2023 |
|---|---|---|
Total operating income | 36,344,416 | 26,904,988 |
Total operating costs | 52,348,325 | 53,543,051 |
Operating result | -16,003,910 | -26,638,063 |
Financial income/costs | 5,858,843 | 14,727,394 |
Profit before tax | -10,145,066 | -11,910,670 |
Total tax & extraordinary income/cost | 0 | 0 |
Annual Total Result | -10,145,066 | -11,910,670 |
Balance overview
| Year | 2025 | 2023 |
|---|---|---|
Total fixed assets | 0 | 645,315,226 |
Total current assets | 0 | 208,269,039 |
Total assets | 0 | 853,584,265 |
Short term debt | 0 | 84,317,125 |
Long term debt | 0 | 0 |
Total liabilities | 0 | 84,317,125 |
Contributed capital | 0 | 769,267,140 |
Retained earnings | 0 | 0 |
Total equity | 0 | 769,267,140 |
Total equity and liabilities | 0 | 853,584,265 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises